Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

H. Lee Moffitt Cancer Center and Research Institute · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
lung-cancernon-small-cell-lung-cancer
non small cell lung cancer, stage iv non-small cell lung cancer, recurrent non small cell lung cancer, lung cancer, tumor-infiltrating lymphocytes, egfr mutation, alk rearrangement, ros1 rearrangement, erbb2 mutation, her2 exon 20 mutation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 836486
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.